Biotech jumps 41% on promising drug to treat rare lung disease
July 11, 2017 at 09:14 AM EDT
Shares of the biotech surged more than 41 percent on the news in pre-market trading Tuesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.